Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients
Christine M. Durand(University of Maryland, Baltimore), Niraj M. Desai(Johns Hopkins University), Darin Ostrander(Johns Hopkins University), Dorry L. Segev(New York University), Mary G. Bowring(Johns Hopkins University), Mark Sulkowski(Johns Hopkins University), Jeremy Sugarman(Johns Hopkins Berman Institute of Bioethics), Diane Brown(Johns Hopkins University), Michael A. Chattergoon(Vir Biotechnology (Switzerland)), Ashraf Reyad(Johns Hopkins University), Nichole Bair(Johns Hopkins University), Russell Wesson(Johns Hopkins University), Fizza Naqvi(Johns Hopkins University), Guido Massaccesi(University of Maryland, Baltimore)
Cited by 295
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k